FRANCISCO ANTONIO
GÓMEZ VEIGA
Investigador en el periodo 2014-2021
University Medical Center Hamburg-Eppendorf
Hamburgo, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Hamburg-Eppendorf (2)
2017
-
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
The Lancet Oncology, Vol. 18, Núm. 2, pp. 181-191
2015
-
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the zometa european study (ZEUS)
European Urology, Vol. 67, Núm. 3, pp. 482-491